Search

Research

Listed are The Kids Research Institute Australia research teams involved in our Genetics and Rare Diseases Program. This program sits under the Chronic and Severe Diseases research theme.

The Global Disease Modelling group informs development and implementation of drugs, medical treatments and non-medical interventions to effectively tackle disease. They build mathematical models of diseases, designed to take into account the complex constellation of interactions between pathogens, humans, diseases, the environment and entire healthcare systems.

Tourette syndrome is a neurodevelopmental disorder characterised by uncontrollable movements and vocalisations known as tics.

Research

This 2nd edition is intended for staff and students and all health practitioners working in areas that support Indigenous mental health and wellbeing.

Focus Area

The Indigenous Health research theme integrates the needs of Indigenous families and children into all relevant areas of our work. Improving the health and well-being of Indigenous children and families is an overarching priority for every program and team at the Institute.

WAACHS was the largest and most comprehensive survey ever undertaken into the health, wellbeing & development of WA Aboriginal and Torres Strait Islander kids

Improving the educational experiences of Aboriginal children and young people

Research

Listed are all The Kids Research Institute Australia research teams involved in our Disability Program. This program sits under the Brain and Behaviour research theme.

Research

The eradication of smallpox is considered one of the greatest achievements of humankind, thanks to vaccination. The widespread availability of childhood vaccines has substantially reduced childhood morbidity and mortality. Devastating infections, such as polio, have almost disappeared due to vaccination. In 2021, it was estimated that vaccination against ten selected pathogens will have averted 69 million deaths between 2000 and 2030. Increases in vaccine coverage and introduction of additional vaccines should reduce lifetime mortality by 72% in the 2019 birth cohort. However, access to vaccines that prevent life-threatening and disabling infectious diseases remains unequal.

Research

Acute leukemia continues to be a major cause of death from disease worldwide and current chemotherapeutic agents are associated with significant morbidity in survivors. While better and safer treatments for acute leukemia are urgently needed, standard drug development pipelines are lengthy and drug repurposing therefore provides a promising approach.